TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
PuraPharm Corp. Ltd. ( (HK:1498) ) has shared an announcement.
PuraPharm Corporation Limited has announced the appointment of Dr. Kam Biu Tsoi as an executive director effective June 30, 2025. Dr. Tsoi, who has over 40 years of experience in sales management and Chinese medicine, will also join the company’s nomination committee. His appointment is expected to strengthen the company’s leadership in the Chinese medicine sector, given his extensive background and previous association with the company.
More about PuraPharm Corp. Ltd.
PuraPharm Corporation Limited is a company involved in the Chinese medicine and healthcare products industry. It focuses on the development, production, and sales of traditional Chinese medicine products.
Average Trading Volume: 117,268
Technical Sentiment Signal: Sell
Current Market Cap: HK$189.6M
For detailed information about 1498 stock, go to TipRanks’ Stock Analysis page.